Australians undergoing open-heart surgery could soon benefit from safer, simpler care and get home earlier thanks to the ...
Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...
Chicago-based Cardiosense has received 510(k) clearance from the FDA for its CardioTag device, a multimodal wearable sensor. The CardioTag is designed to provide clinicians with a comprehensive, ...
Vanderbilt Anesthesiologists Use Smaller Probes to Monitor Cardiac Function Cardiothoracic anesthesiologists from Vanderbilt University Medical Center are pioneering the use of a smaller ultrasound ...
Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to ...
When the heart struggles to pump efficiently, a cascade of events unfolds. Fluid accumulates in the lungs and extremities. Breathing becomes labored. Simple activities like climbing stairs or carrying ...
You can trust Cyclingnews Our experts spend countless hours testing cycling tech and will always share honest, unbiased advice to help you choose. Find out more about how we test. The Polar H10 heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results